Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rewati Prakash
Institutions:
Research Institute of the McGill University Health Centre,
McGill University
Observed institutions:
Research Institute of the McGill University Health Centre,
McGill University
ORCID:
0009-0005-2098-6561
Observed ORCID:
0009-0005-2098-6561
OpenAlex ID:
A5089753544
Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives
2022
·
Benjamin N. Forgie
, Rewati Prakash
, et al.
·
International Journal of Molecular Sciences
·
100
PDF
Vitality, viability, long-term clonogenic survival, cytotoxicity, cytostasis and lethality: what do they mean when testing new investigational oncology drugs?
2024
·
Benjamin N. Forgie
, Rewati Prakash
, et al.
·
Discover Oncology
·
39
PDF
Cancer cell repopulation after therapy: which is the mechanism?
2023
·
Rewati Prakash
, Carlos M. Telleria
·
Oncoscience
·
9
PDF
Comparison of two-dimensional and three-dimensional culture systems and their responses to chemotherapy in cells representing disease progression of high-grade serous ovarian cancer
2024
·
Naya El Mokbel
, Alicia A. Goyeneche
, et al.
·
Biochemistry and Biophysics Reports
·
4
Nelfinavir Synergizes with Cisplatin and Promotes GSDME-Associated Lytic Cell Death in Platinum-Resistant Ovarian Cancer Cells
2026
·
Benjamin N. Forgie
, Rewati Prakash
, et al.
·
Pharmaceuticals
·
2
Clinical outcomes and prognostic factors of low-grade serous ovarian cancer: A single-centre observational retrospective study
2026
·
Rewati Prakash
, Asifuzzaman Khan
, et al.
·
medRxiv
·
1
Abstract 364: Oxaliplatin and 5-fluorouracil cause therapy-induced senescence in low-grade serous ovarian cancer cells
2025
·
Rewati Prakash
, Alicia A. Goyeneche
, et al.
·
Cancer Research
·
1
Oxaliplatin and 5-Fluorouracil induce p53-p21-pRb-associated cell cycle arrest and a transient senescence-like phenotype in patient-derived low-grade serous ovarian cancer cells
2026
·
Rewati Prakash
, Benjamin N Forgie
, et al.
·
bioRxiv (Cold Spring Harbor Laboratory)
PDF
The HIV protease inhibitor nelfinavir synergizes with cisplatin to kill platinum-resistant ovarian cancer cells through DNA damage and double-stranded DNA–triggered inflammatory signaling
2026
·
Carlos M. Telleria
, Benjamin N. Forgie
, et al.
PDF
Abstract A066: The cytotoxic effects of oxaliplatin and 5-fluorouracil against low-grade serous ovarian cancer cells
2024
·
Rewati Prakash
, Alicia A. Goyeneche
, et al.
·
Cancer Research
EP274/#837 Characterization of a three-dimensional culture system representative of disease progression in high-grade serous ovarian cancer
2023
·
Naya El Mokbel
, Alicia Goyeneche
, et al.
·
International Journal of Gynecological Cancer
PDF
Show more works
View as search
Works count:
11
Citation count:
156
H-index:
4
I10-index:
2
Year
Topic
Type